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We studied the influence of the characteristics of oxide porous coatings on osteogenesis and 
integration of new bone tissue and titanium implant surface in the ectopic osteogenesis test. 
Implants with coating with pore size 2-20 µ exhibit better osteogenic and osteoconductive 
characteristics than implants with homogenous surface and smooth relief (pore size 0.5- 
5.0 µ). Physical characteristics of the surface of the material along with chemical composi-
tion of the coating are essential for the formation of bone tissue and its integration with the 
implant.
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The significance of chemical composition and physical 
characteristics of implants for activation of mesen-
chymal stem cells in the osteogenic direction remains 
the object of discussions for scientists engaged in cre-
ation of new materials for traumatology and dentistry 
[4,5,8,9]. However, the results indicating the influence 
of the surface topography on the integration processes 
and bone tissue remodeling are contradictory and re-
quire thorough studies.
Here we analyzed the influence of the charac-
teristics of porous oxide coating on osteogenesis and 
integration of the new bone tissue with the surface of 
a titanium implant.
MATERIALS AND METHODS
The study was carried out on inbred male Wistar rats 
(n=24; 240-250 g). Experiments were carried out with 
due consideration for the international regulations [7] 
and the National standards GOST R ISO 10993-2-
2009 and GOST ISO 10993-6-2011. Specimens of 
titanium alloys with bioactive coatings were implanted 
under the skin of the experimental animals: BT6 al-
loy with large-porous coating (LPC) or BT1-0 pure 
titanium with microporous coating (MPC).
The implants were made using microarc oxida-
tion technology at the Nanostructured Materials and 
Nanotechnologies Science, Education and Innovation 
Centre, Belgorod State National Research University 
[1,2,6]. The thickness of MPC was 11-12 µ, roughness 
(Ra) 1.4-1.6 µ [6]. The thickness of LPC varied within 
25-35 µ, with Ra 5-6 µ. More than 90% of MPC sur-
face was formed by pores <5 µ. For LPC at least 50% 
surface were pores >5 µ, some of them up to 25 µ. 
The surface roughness at the nanolevel (on the surface 
between pores of the µ size) was 80±30 nm for MPC 
and 100±30 nm for LPC. Microporous coating was 
presented by titanium and silicon oxides with calcium 
oxide level no more than 2 mol%, while the molar 
share of calcium oxide in LPC was 40 mol% [6].
Ectopic osteogenesis was studied in vivo [3,10]. 
Eight Wistar rats received syngeneic red bone mar-
row. The animals were sacrificed by ether overdos-
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age, femoral bones were removed under sterile condi-
tions, and red bone marrow cells were isolated. The 
resultant cell suspension was divided into 2 portions. 
One portion was applied onto implants and placed 
in Petri dishes. Experimental samples with implants 
were incubated in DMEM/F-12 (Gibco) supplemented 
with 10% fetal calf serum (HyClone), 100 nmol/li-
ter dexamethasone phosphate (Shreya Life Sciences), 
50 mg/liter ascorbic acid (Sishui Xierkang Pharma-
ceutical Co.). Glycerophosphate (10 mmol/liter; Vec-
tor) was added to the culture medium instead of the 
implants in control samples. The other portion of the 
suspension was applied onto the implants which were 
then incubated for 45 min in DMEM/F-12 (Gibco) and 
implanted subcutaneously.
In experiments in vitro, formalin solution (10%) 
was added to Petri dishes after 14 days and the cul-
tures were stained with 10% Alizarin red (Sigma Al-
drich). Calcium depositions indicating osteogenic dif-
ferentiation of cells were detected under Eclipse E200 
microscope (Nikon).
In vivo, the animals were sacrificed by ether over-
dosage after 60 days, and the implants with tissue 
fragments were removed. The tissue which grew on 
the implant was removed with a scalpel and plunged 
in 10% formalin. Histological preparations were pro-
cessed routinely and stained with hematoxylin and 
eosin. Histological analysis was carried out under an 
Eclipse E200 microscope (Nikon). The area of new 
bone tissue was evaluated using NIS Elements D soft-
ware (Nikon).
Scanning of the implant surface with evaluation 
of the morphology and integration of connective tis-
sue elements were carried out using Quanta 200 3D 
scanning electron microscope (FEI Company). Bone 
tissue was differentiated from loose and compact con-
nective tissue by weight content (wt%) of calcium and 
phosphorus using an attachment for X-ray spectral 
microanalysis (EDAX).
The results were statistically processed using Sta-
tistica 6.0 software.
RESULTS
Calcium-positive staining was found in experimental 
and control samples in vitro, no appreciable differ-
ences between them were detected (Fig. 1, a). In vivo, 
no signs of inflammatory reaction and tissue infection 
were detected 2 months after subcutaneous implanta-
tion of specimens with bioactive coating.
Macroscopic analysis of the implants showed con-
nective tissue layers on the surface of all specimens. 
Bone tissue layers were clearly seen in the BT6-LPC 
group (Fig. 1, b), while in the BT1-0-MPC group, 
small fragments of bone tissue were surrounded by 
fibers of loose and compact connective tissue. His-
tological studies revealed the largest bone tissue area 
on BT6-LPC samples (800±2 µ2 vs. 300±4 µ2 on the 
BT1-0-MPC implants).
Studies of implants in a scanning electron micro-
scope confirmed the presence of fibrous connective 
tissue layers and bone tissue on the surfaces of speci-
mens of both kinds (Fig. 2). Massive bone trabeculae 
alternating with compactly packed fibrillar structures 
forming a homogenous layer, were clearly seen on 
the surface of BT6-LPC implants. A different picture 
was seen on the surface of BT1-0-MPC implants: 
bone trabeculae were smaller and enveloped in fibril-
lar structures of various diameters with gaps between 
fragments.
Analysis of characteristic X-ray spectra showed 
the content of macroelements in fibrillar structures in 
Fig. 1. Fragments of connective tissue formed in contact with BT6-LPC implant. a) Micropreparation, Ch30; in vitro — osteogenic cells, 
preosteoblasts round the implant; b) micropreparation, ×100; in vivo — bone tissue surrounded by fibers of loose and compact connective 
tissue.
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all groups: calcium — 33±6 wt%, phosphorus 67±6 
wt%. The content of calcium in new bone tissue tra-
beculae on BT6-LPC implants was 63±6 wt% and 
phosphorus 37±6 wt% vs. 60±6 and 40±6 wt% for 
calcium and phosphorus, respectively, on BT1-0-MPC 
implants — hence, no appreciable differences between 
the groups were detected.
All implants used for subcutaneous inoculation 
are biocompatible. In vitro experiments showed that 
the presence of calcium-phosphorus layer on the im-
plants promoted osteogenic differentiation of red bone 
marrow cells. The results of in vivo experiments in-
dicate better osteogenic and osteoconductive charac-
teristics of BT6-LPC implants. Well-developed sur-
face relief of the implants with pores of various sizes 
forming channels in the inner layers, promotes rapid 
penetration of osteogenic cells, fibers, and bioactive 
substances essential for regeneration processes, into 
the depth of the implant. Homogenous surface relief 
of BT1-0-MPC does not stimulate the osteogenic and 
osteoconductive characteristics of these implants. 
Roughness of the surface at the nanolevel seems to be 
inessential in vivo; presumably, this parameter works 
at the earlier stages of bone tissue formation.
Hence, a space with 3D organization of the struc-
ture and sufficient levels of calcium phosphates in the 
coating of the material are obligatory conditions for 
the formation and integration of bone tissue with the 
implant.
The study was carried out on the equipment of 
Centre of Common Use “Diagnosis of Nanomaterials 
Structure and Characteristics”, Belgorod State Na-
tional Research University.
Fig. 2. Fragments of new bone tissue on the surface of BT6-LPC implant (a, ×6000) and BT1-0-MPC implant (b, ×4000) with abundant 
compact fibrous connective tissue.
REFERENCES
 1. Еrubaev EA, Kolobov YR, Kuzmenko IN, Khramov GV, Iva-
nov MB, Manokhin SS. The influence of micro-arc oxida-
tion on the fatigue titanium alloy VT6. Fundament. Issled. 
2014;(12):2575-2579. Russian.
 2. Kolobov YR. Nanotechnologies for the formation of medical 
implants based on titanium alloys with bioactive coatings. 
Nanotechnol. Rus. 2009;4(11-12):758-775.
 3. Khlusov IA, Karlov AV, Pozhen’ko NS, Sukhodolo IV, Khluso-
va MY. Relationship between osteogenic characteristics of 
bone marrow cells and calcium phosphate surface relief and 
solubility. Bull. Exp. Biol. Med. 2006;141(1):99-103.
 4. Cyster LA, Grant DM, Howdle SM, Rose FR, Irvine DJ, Free-
man D, Scotchford CA, Shakesheff KM. The influence of 
dispersant concentration on the pore morphology of hydroxy-
apatite ceramics for bone tissue engineering. Biomaterials. 
2005;26(7):697-702.
 5. Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Her-
zyk P, Wilkinson CD, Oreffo RO. The control of human mes-
enchymal cell differentiation using nanoscale symmetry and 
disorder. Nat. Mater. 2007;6(12):997-1003.
 6. Gazizova MYu, Ivanov MB, Vershinina T.N. Investigation 
of corrosion behavior of bioactive coverings on commer-
cially pure titanium and its alloys. J. Nano-Electron. Phys. 
2015;7(4):04081(3).
 7. Guide for the Care and Use of Laboratory Animals. Washing-
ton, 2011.
 8. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaf-
folds and osteogenesis. Biomaterials. 2005;26(27):5474-5491.
 9. Li J, Dou Y, Yang J, Yin Y, Zhang H, Yao F, Wang H, Yao K. 
Surface characterization and biocompatibility of micro- and 
nano-hydroxyapatite/chitosan-gelatin network films. Mater. 
Sci. Eng: C. 2009;29(4):1207-1215.
10. Scott MA, Levi B, Askarinam A, Nguyen A, Rackohn T, Ting 
K, Soo C, James AW. Brief review of models of ectopic bone 
formation. Stem Cells Dev. 2012;21(5):655-667.
Bulletin  of  Experimental  Biology  and  Medicine,  Vol.  162,  No.  6,  April,  2017  BIOTECHNOLOGIES
